Stay updated on Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial page.
Latest updates to the Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial page
- Check2 days agoChange DetectedThe Locations section was expanded to include many new sites across the United States, Australia, and Europe, while several previously listed locations were removed.SummaryDifference4%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedNo core study data changed; minor editorial updates were made (e.g., added 'Melanoma' keyword, related topics like MedlinePlus Genetics, and updated publication notes). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check38 days agoChange DetectedThe government funding notice and the Melanoma-related topics section (including MedlinePlus Genetics) were removed from the page.SummaryDifference0.2%
- Check45 days agoChange DetectedAdded Melanoma keyword tag and a Related Topics section linking to MedlinePlus Genetics on the study page, representing metadata enhancements. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check52 days agoChange DetectedAdded Melanoma as a topic and a related topic link to MedlinePlus Genetics under related topics; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check60 days agoChange DetectedMelanoma is no longer listed as the study condition. The related topic 'MedlinePlus Genetics' has been removed from the related topics section.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial page.